Founded in 2015, DBG Health is a diversified group delivering pharmaceuticals, consumer brands, health services, and pharmacy support across Australia, the United States, and Europe. With over 1,000 employees and more than $2 billion in revenue, DBG Health is the largest Australian-owned pharmaceutical provider by PBS prescription volume and a market leader in generics, OTC, and personal care products.
This offer is not an offer of securities listed on the ASX or any other stock exchange or public market and is not open to the general public.
Indirectly invest in the growth of DBG, a company with a proven track record in the pharmaceutical, OTC and beauty sectors.
Redemption may be in the form of cash or conversion into fully paid ordinary shares of DBG (or a future listed entity).
This offer is available only to selected Head Office customers of DBG Health.
Retention of RPS is tied to ongoing compliance with franchise agreements by participating pharmacy groups.
| Event | Date |
|---|---|
| Prospectus Lodgement Date | 3 September 2026 |
| Offer Opens | 11 September 2026 |
| RPS Issuance Begins | From time to time during the Offer Period on dates determined by the Company in its sole and absolute discretion. |
| Offer Closes | 27 September 2027 |
| Expected dispatch of holding statement | Within 10 Business Days of an Issue Date |
Dates subject to change. Applicants are encouraged to act early.
This Offer is open to residents of Australia only. By accessing the prospectus, you acknowledge that you are a resident of Australia.
Eligible Head Offices will receive an invitation with their allocation.